Dr Reddys Laboratories Shares Rise for Third Consecutive Session Amid Market Gains
Dr Reddys Laboratories Ltd shares have risen for the third consecutive session, trading around Rs 1240 with increased volume compared to the monthly average. Over the past year, the stock gained approximately 1.58%, outperforming the NIFTY and Nifty Pharma indices, which declined. The stock's price-to-earnings ratio varies between sources, with one reporting 32.15 and another 153.77 based on trailing twelve months earnings. Market capitalization stands near Rs 103,767 crore as of late September 2026.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (58/100). Lens Score 28/100.
Outlets measured: businessstandard, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–65/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 29 Sept, 04:17 am. Other outlets followed.
- 1